Literature DB >> 34916215

Covid-19: Runny nose, headache, and fatigue are commonest symptoms of omicron, early data show.

Gareth Iacobucci1.   

Abstract

Entities:  

Year:  2021        PMID： 34916215     DOI： 10.1136/bmj.n3103

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  30 in total

1.  Use of a Screening Protocol to Identify Asymptomatic COVID-19 in a Free Community Health Clinic in Shelby County, Alabama, October 2020-February 2021.

Authors:  James R Kilgore; Justin R Johnston; Barbara Van Der Pol; Peng Li; Mark Wilson; William Curry; Cynthia Selleck
Journal:  Public Health Rep       Date:  2022-07-21       Impact factor: 3.117

2.  An integrated analysis and comparison of serum, saliva and sebum for COVID-19 metabolomics.

Authors:  Matt Spick; Holly-May Lewis; Cecile F Frampas; Katie Longman; Catia Costa; Alexander Stewart; Deborah Dunn-Walters; Danni Greener; George Evetts; Michael J Wilde; Eleanor Sinclair; Perdita E Barran; Debra J Skene; Melanie J Bailey
Journal:  Sci Rep       Date:  2022-07-13       Impact factor: 4.996

3.  Clinical Characteristics of Omicron SARS-CoV-2 Variant Infection After Non-mRNA-Based Vaccination in China.

Authors:  Qing-Lei Zeng; Yuan-Jun Lv; Xiao-Jing Liu; Zhi-Yong Jiang; Shuo Huang; Wei-Zhe Li; Zu-Jiang Yu
Journal:  Front Microbiol       Date:  2022-06-30       Impact factor: 6.064

Review 4.  Emerging evidence on Omicron (B.1.1.529) SARS-CoV-2 variant.

Authors:  Vineet Sharma; Himanshu Rai; Dev N S Gautam; Pradeep K Prajapati; Rohit Sharma
Journal:  J Med Virol       Date:  2022-02-03       Impact factor: 20.693

5.  Letter to the editor: Time to consider unusual or severe headache and fatigue as indicator symptoms for COVID-19 testing?

Authors:  Alma Tostmann
Journal:  Euro Surveill       Date:  2022-01

Review 6.  Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic.

Authors:  Rekha Khandia; Shailja Singhal; Taha Alqahtani; Mohammad Amjad Kamal; Nahed A El-Shall; Firzan Nainu; Perumal Arumugam Desingu; Kuldeep Dhama
Journal:  Environ Res       Date:  2022-01-29       Impact factor: 8.431

Review 7.  Rickettsiosis in Southeast Asia: Summary for International Travellers during the COVID-19 Pandemic.

Authors:  Thundon Ngamprasertchai; Borimas Hanboonkunupakarn; Watcharapong Piyaphanee
Journal:  Trop Med Infect Dis       Date:  2022-01-27

8.  Assessment 2 months after the administration of a 3rd dose mRNA: a new variant-adapted vaccine is expected.

Authors:  Marie Tré-Hardy; Roberto Cupaiolo; Alain Wilmet; Thomas Antoine-Moussiaux; Nicoleta Coman-Vlagea; Andrea Della Vecchia; Alexandra Horeanga; Emmanuelle Papleux; Marc Vekemans; Ingrid Beukinga; Laurent Blairon
Journal:  J Infect       Date:  2022-02-16       Impact factor: 38.637

9.  The SARS-CoV-2 Omicron (B.1.1.529) variant and the re-emergence of COVID-19 in Europe: An alarm for Bangladesh.

Authors:  Md Rabiul Islam
Journal:  Health Sci Rep       Date:  2022-03-13

10.  Telephone-Based Structured Communication Simulation Program for the Follow-Up of COVID-19 Cases and Contacts in Primary Care.

Authors:  María Gracia Adánez-Martínez; Ismael Jiménez-Ruiz; César Carrillo-García; José Luis Díaz-Agea; Antonio Jesús Ramos-Morcillo; Alonso Molina-Rodríguez; María Ruzafa-Martínez; César Leal-Costa
Journal:  Int J Environ Res Public Health       Date:  2022-03-25       Impact factor: 3.390
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.